Seven protective miRNA signatures for prognosis of cervical cancer

被引:22
|
作者
Liu, Bei [1 ]
Ding, Jin-feng [2 ]
Luo, Jian [3 ]
Lu, Li [4 ,5 ]
Yang, Fen [6 ]
Tan, Xiao-dong [1 ]
机构
[1] Wuhan Univ, Sch Publ Hlth, Wuhan 430071, Peoples R China
[2] Taizhou Hosp, Dept Anesthesiol, Taizhou 317000, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Geriatr Med, Wuhan 430030, Peoples R China
[4] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, Canc Epigenet Lab, Hong Kong 999077, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong 999077, Hong Kong, Peoples R China
[6] Hubei Univ Chinese Med, Dept Nursing, Wuhan 430063, Peoples R China
关键词
cervical cancer; survival analysis; Cox's model; GO enrichment; pathway analysis; TUMOR-GROWTH; COLON-CANCER; PROLIFERATION; INFORMATION; MIR-142-3P; EXPRESSION; BIOMARKER; SURVIVAL; INVASION; MIR-150;
D O I
10.18632/oncotarget.10678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer is the second cause of cancer death in females in their 20s and 30s, but there were limited studies about its prognosis. This study aims to identify miRNA related to prognosis and study their functions. TCGA data of patients with cervical cancer were used to build univariate Cox's model with single clinical parameter or miRNA expression level. Multivariate Cox's model was built using both clinical information and miRNA expression levels. At last, STRING was used to enrich gene ontology or pathway for validated targets of significant miRNAs, and visualize the interactions among them. Using univariate Cox's model with clinical parameters, we found that two clinical parameters, tobacco use and clinical stage, and seven miRNAs were highly correlated with the survival status. Only using the expression level of miRNA signatures, the model could separate patients into high-risk and low-risk groups successfully. An optimal feature-selected model was proposed based on two clinical parameters and seven miRNAs. Functional analysis of these seven miRNAs showed they were associated to various pathways related to cancer, including MAPK, VEGF and P53 pathways. These results helped the research of identifying targets for targeted therapy which could potentially allow tailoring of treatment for cervical cancer patients.
引用
收藏
页码:56690 / 56698
页数:9
相关论文
共 50 条
  • [21] Circulating miRNA Signatures: Promising Prognostic Tools for Cancer
    Heneghan, Helen M.
    Miller, Nicola
    Kerin, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : E573 - E574
  • [22] Identification of miRNA signatures and their therapeutic potentials in prostate cancer
    Abdullah Karadag
    Ata Ozen
    Mete Ozkurt
    Cavit Can
    Ibrahim Bozgeyik
    Selda Kabadere
    Ruhi Uyar
    Molecular Biology Reports, 2021, 48 : 5531 - 5539
  • [23] Identification of miRNA signatures and their therapeutic potentials in prostate cancer
    Karadag, Abdullah
    Ozen, Ata
    Ozkurt, Mete
    Can, Cavit
    Bozgeyik, Ibrahim
    Kabadere, Selda
    Uyar, Ruhi
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5531 - 5539
  • [24] Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer
    Jin, Tianzhe
    Yin, Taotao
    Xu, Ruiyi
    Liu, Hong
    Yuan, Shuo
    Xue, Yite
    Zhang, Jianwei
    Wang, Hui
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [25] Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
    dos Anjos, Laura Gonzalez
    de Almeida, Bruna Cristine
    de Almeida, Thais Gomes
    Lavorato Rocha, Andre Mourao
    Maffazioli, Giovana De Nardo
    Soares, Fernando Augusto
    da Cunha, Isabela Werneck
    Baracat, Edmund Chada
    Carvalho, Katia Candido
    CANCERS, 2018, 10 (09)
  • [26] miRNA profiling for diagnosis and prognosis of human cancer
    Jay, Chris
    Nemunaitis, John
    Chen, Patrick
    Fulgham, Pat
    Tong, Alex W.
    DNA AND CELL BIOLOGY, 2007, 26 (05) : 293 - 300
  • [27] A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer
    Qiu, Huajuan
    Liang, Duoxian
    Liu, Limin
    Xiang, Qun
    Yi, Zhijun
    Ji, Yanqin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [28] Are there molecular signatures for predicting bladder cancer prognosis?
    Lokeshwar, Vinata B.
    JOURNAL OF UROLOGY, 2006, 176 (06): : 2347 - 2348
  • [29] Immune Signatures Predict Prognosis in Localized Cancer
    Hsu, David S.
    Kim, Mickey K.
    Balakumaran, Bala S.
    Acharya, Chaitanya R.
    Anders, Carey K.
    Clay, Tim
    Lyerly, H. Kim
    Drake, Charles G.
    Morse, Michael A.
    Febbo, Phillip G.
    CANCER INVESTIGATION, 2010, 28 (07) : 765 - 773
  • [30] Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
    Liu, Xinyu
    Zhou, Lei
    Gao, Minghui
    Dong, Shuhong
    Hu, Yanan
    Hu, Chunjie
    FRONTIERS IN GENETICS, 2022, 13